Front Row Advisors LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2019$7,000
+40.0%
610.0%0.01%
+25.0%
Q1 2019$5,000
-16.7%
610.0%0.00%
-20.0%
Q4 2018$6,0000.0%610.0%0.01%
+25.0%
Q3 2018$6,000
+50.0%
61
+60.5%
0.00%
+33.3%
Q2 2018$4,000380.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders